Neurocrine

Teva’s Huntington Drug Hits A Snag, Lifting Rival Neurocrine
Investors.com
Wed, 06/1/16 - 10:14 am
Teva Pharmaceutical
Huntington's disease
Neurocrine
SD-809
valbenazine
Positive PhIII leaves Neurocrine lining up for an FDA filing for tardive dyskinesia
Fierce Biotech
Thu, 10/8/15 - 09:32 am
Neurocrine
FDA
NBI-98854
tardive dyskinesia
Neurocrine hits the brakes on its genetic disease drug
Fierce Biotech
Tue, 06/9/15 - 10:16 am
Neurocrine
NBI-77860
congenital adrenal hyperplasia
AbbVie, Neurocrine drug successful in endometriosis trial
Yahoo/Reuters
Thu, 01/8/15 - 08:52 am
AbbVie
Neurocrine
endometriosis
Elagolix
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Mon, 01/27/14 - 09:21 am
Avanir
BioDelivery Sciences
Conatus Pharmaceuticals
Geron
Halozyme
Neurocrine
Orexigen
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
TheStreet.com
Tue, 01/21/14 - 09:37 am
biotech
Intercept Pharma
Rexahn
CorMedix
Neurocrine
Cell Therapeutics
What Biotech Pros Will Be Chirping About at JP Morgan This Week
Xconomy
Mon, 01/13/14 - 10:47 am
JPMHC 2014
biotech
renal denervation
Intercept Pharma
Neurocrine
Illumina
Ion Torrent
Medtronic
innovation
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
AbbVie Has Excellent Management Efficiency, But Is It A Buy?
Seeking Alpha
Fri, 09/13/13 - 08:36 am
AbbVie
Neurocrine
Abbott Labs
Neurocrine And ChemoCentryx: Phase II Data Disappoints
Seeking Alpha
Wed, 09/11/13 - 11:25 am
Neurocrine
ChemoCentryx
CCX140
NBI-98854
tardive dyskinesia
diabetic nephropathy
How Safe is AbbVie from Niacin’s Woes?
Motley Fool
Thu, 03/21/13 - 11:12 am
AbbVie
niacin
Niaspan
Merck
Biogen Idec
Neurocrine
Neurocrine's VMAT-2 Enters Phase IIb
Seeking Alpha
Wed, 10/3/12 - 10:52 am
Neurocrine
Abbott Labs
tardive dyskinesia
NBI-98854
VMAT-2 inhibitor
Healthcare Business Review: GenVec’s Conference Success, Neurocrine Begins Trials
Wall St. Cheat Sheet
Tue, 10/2/12 - 10:30 am
GenVec
Neurocrine
NBI-98854
Neurocrine Biosciences Earnings: Mixed Results
Wall St. Cheat Sheet
Tue, 07/31/12 - 06:44 pm
Neurocrine
earnings
Neurocrine's News Not As Bad As The Market Thinks
Seeking Alpha
Wed, 03/28/12 - 10:20 am
Neurocrine
Abbott Laboratories
NBI-98854
tardive dyskinesia
Neurocrine Could Be A Major Biotech Comeback Story
Seeking Alpha
Tue, 03/20/12 - 10:14 am
Neurocrine
Abbott Laboratories
GSK
Neurocrine Biosciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thu, 02/9/12 - 09:28 am
earnings
Neurocrine
Neurocrine Biosciences Still Worth Watching
Seeking Alpha
Fri, 02/3/12 - 09:51 am
Neurocrine
Neurocrine Biosciences' Positive Surge Was Not Unexpected
Seeking Alpha
Wed, 11/2/11 - 11:51 am
Neurocrine
Abbott Laboratories
Neurocrine Looks Well-Positioned For The Future
Seeking Alpha
Tue, 11/1/11 - 06:11 pm
Neurocrine
earnings

Pages